Cargando…
The synergy and mode of action of quercetin plus amoxicillin against amoxicillin-resistant Staphylococcus epidermidis
BACKGROUND: Staphylococcus epidermidis is one of the most multiple resistances to antibiotics in the recent years. Therefore, practically-prescribed antibiotics in the treatment of these strains are not effective. Plant-derived antibacterial is one of the most interesting sources of new therapeutics...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973372/ https://www.ncbi.nlm.nih.gov/pubmed/27491399 http://dx.doi.org/10.1186/s40360-016-0083-8 |
_version_ | 1782446395909734400 |
---|---|
author | Siriwong, Supatcharee Teethaisong, Yothin Thumanu, Kanjana Dunkhunthod, Benjawan Eumkeb, Griangsak |
author_facet | Siriwong, Supatcharee Teethaisong, Yothin Thumanu, Kanjana Dunkhunthod, Benjawan Eumkeb, Griangsak |
author_sort | Siriwong, Supatcharee |
collection | PubMed |
description | BACKGROUND: Staphylococcus epidermidis is one of the most multiple resistances to antibiotics in the recent years. Therefore, practically-prescribed antibiotics in the treatment of these strains are not effective. Plant-derived antibacterial is one of the most interesting sources of new therapeutics. The present study was to investigate antibacterial, synergy and modes of action of quercetin and amoxicillin against amoxicillin-resistant Staphylococcus epidermidis (ARSE). METHODS: The MICs, checkerboard assay, viability curves, cytoplasmic membrane (CM) permeability, enzyme assay, transmission electron microscopy, confocal microscopy and FT-IR microspectroscopy measurement was performed. RESULTS: The MICs of amoxicillin, penicillin, quercetin and kaempferol against all ARSE strains were 16, 200, 256-384 and >1024 μg/mL respectively. Synergistic effects were exhibited on amoxicillin plus quercetin and penicillin plus kaempferol against these strains at FIC index 0.50 and <0.38 respectively. The synergistic activity of quercetin plus amoxicillin was confirmed by the viable count. This combination increased CM permeability, caused marked morphological, peptidoglycan and cytoplasmic membrane damage, increased protein amide I and II, but decreased fatty acid in bacterial cells. The quercetin had an inhibitory activity against β-lactamase. CONCLUSIONS: So, these findings are the first report that quercetin has the synergistic effect with amoxicillin against ARSE via four modes of actions, inhibit peptidoglycan synthesis and β-lactamases activity, increase CM permeability and protein amide I and II but decrease fatty acid in bacterial cells. Of course, this flavonol has the dominant potential to develop a brand-new collateral phytochemical agent plus amoxicillin to treat ARSE. Future work should focus on the bioavailability, efficacy and toxicity in animal and human studies, as well as, the synergistic effect on blood and tissue should be evaluated and achieved. |
format | Online Article Text |
id | pubmed-4973372 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-49733722016-08-05 The synergy and mode of action of quercetin plus amoxicillin against amoxicillin-resistant Staphylococcus epidermidis Siriwong, Supatcharee Teethaisong, Yothin Thumanu, Kanjana Dunkhunthod, Benjawan Eumkeb, Griangsak BMC Pharmacol Toxicol Research Article BACKGROUND: Staphylococcus epidermidis is one of the most multiple resistances to antibiotics in the recent years. Therefore, practically-prescribed antibiotics in the treatment of these strains are not effective. Plant-derived antibacterial is one of the most interesting sources of new therapeutics. The present study was to investigate antibacterial, synergy and modes of action of quercetin and amoxicillin against amoxicillin-resistant Staphylococcus epidermidis (ARSE). METHODS: The MICs, checkerboard assay, viability curves, cytoplasmic membrane (CM) permeability, enzyme assay, transmission electron microscopy, confocal microscopy and FT-IR microspectroscopy measurement was performed. RESULTS: The MICs of amoxicillin, penicillin, quercetin and kaempferol against all ARSE strains were 16, 200, 256-384 and >1024 μg/mL respectively. Synergistic effects were exhibited on amoxicillin plus quercetin and penicillin plus kaempferol against these strains at FIC index 0.50 and <0.38 respectively. The synergistic activity of quercetin plus amoxicillin was confirmed by the viable count. This combination increased CM permeability, caused marked morphological, peptidoglycan and cytoplasmic membrane damage, increased protein amide I and II, but decreased fatty acid in bacterial cells. The quercetin had an inhibitory activity against β-lactamase. CONCLUSIONS: So, these findings are the first report that quercetin has the synergistic effect with amoxicillin against ARSE via four modes of actions, inhibit peptidoglycan synthesis and β-lactamases activity, increase CM permeability and protein amide I and II but decrease fatty acid in bacterial cells. Of course, this flavonol has the dominant potential to develop a brand-new collateral phytochemical agent plus amoxicillin to treat ARSE. Future work should focus on the bioavailability, efficacy and toxicity in animal and human studies, as well as, the synergistic effect on blood and tissue should be evaluated and achieved. BioMed Central 2016-08-04 /pmc/articles/PMC4973372/ /pubmed/27491399 http://dx.doi.org/10.1186/s40360-016-0083-8 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Siriwong, Supatcharee Teethaisong, Yothin Thumanu, Kanjana Dunkhunthod, Benjawan Eumkeb, Griangsak The synergy and mode of action of quercetin plus amoxicillin against amoxicillin-resistant Staphylococcus epidermidis |
title | The synergy and mode of action of quercetin plus amoxicillin against amoxicillin-resistant Staphylococcus epidermidis |
title_full | The synergy and mode of action of quercetin plus amoxicillin against amoxicillin-resistant Staphylococcus epidermidis |
title_fullStr | The synergy and mode of action of quercetin plus amoxicillin against amoxicillin-resistant Staphylococcus epidermidis |
title_full_unstemmed | The synergy and mode of action of quercetin plus amoxicillin against amoxicillin-resistant Staphylococcus epidermidis |
title_short | The synergy and mode of action of quercetin plus amoxicillin against amoxicillin-resistant Staphylococcus epidermidis |
title_sort | synergy and mode of action of quercetin plus amoxicillin against amoxicillin-resistant staphylococcus epidermidis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973372/ https://www.ncbi.nlm.nih.gov/pubmed/27491399 http://dx.doi.org/10.1186/s40360-016-0083-8 |
work_keys_str_mv | AT siriwongsupatcharee thesynergyandmodeofactionofquercetinplusamoxicillinagainstamoxicillinresistantstaphylococcusepidermidis AT teethaisongyothin thesynergyandmodeofactionofquercetinplusamoxicillinagainstamoxicillinresistantstaphylococcusepidermidis AT thumanukanjana thesynergyandmodeofactionofquercetinplusamoxicillinagainstamoxicillinresistantstaphylococcusepidermidis AT dunkhunthodbenjawan thesynergyandmodeofactionofquercetinplusamoxicillinagainstamoxicillinresistantstaphylococcusepidermidis AT eumkebgriangsak thesynergyandmodeofactionofquercetinplusamoxicillinagainstamoxicillinresistantstaphylococcusepidermidis AT siriwongsupatcharee synergyandmodeofactionofquercetinplusamoxicillinagainstamoxicillinresistantstaphylococcusepidermidis AT teethaisongyothin synergyandmodeofactionofquercetinplusamoxicillinagainstamoxicillinresistantstaphylococcusepidermidis AT thumanukanjana synergyandmodeofactionofquercetinplusamoxicillinagainstamoxicillinresistantstaphylococcusepidermidis AT dunkhunthodbenjawan synergyandmodeofactionofquercetinplusamoxicillinagainstamoxicillinresistantstaphylococcusepidermidis AT eumkebgriangsak synergyandmodeofactionofquercetinplusamoxicillinagainstamoxicillinresistantstaphylococcusepidermidis |